* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Sunday, September 7, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    The Secret to What Made ‘CarJack’ Work on As the World Turns – yahoo.com

    The Surprising Secret Behind ‘CarJack’s’ Success on As the World Turns

    Victor Garber on his viral “And Just Like That” toilet scene: ‘I was delighted to be doing something ridiculous’ (exclusive) – yahoo.com

    Victor Garber on his viral “And Just Like That” toilet scene: ‘I was delighted to be doing something ridiculous’ (exclusive) – yahoo.com

    Pendulum Announce Homecoming 2026 Australian Tour – yahoo.com

    Pendulum Announces Thrilling Homecoming Tour Across Australia in 2026

    ITV Studios Launches New Entertainment Label – Global Bulletin – IMDb

    ITV Studios Unveils Exciting New Entertainment Label

    TS Entertainment bringing Malibu Jack’s to former Owensboro mall – Lane Report

    TS Entertainment Launches Malibu Jack’s at Former Owensboro Mall Location

    Jenny Han Dropped a Major ‘The Summer I Turned Pretty’ Easter Egg Revealing [SPOILER] – yahoo.com

    Jenny Han Just Unveiled a Huge ‘The Summer I Turned Pretty’ Easter Egg That Changes Everything [SPOILER]

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Health Technology Ecosystem – Centers for Medicare & Medicaid Services | CMS (.gov)

    Discover the Future of Health Technology: Innovations Revolutionizing Patient Care

    Coherent Joins LLNL’s STARFIRE Diode Technology Working Group to Advance Inertial Fusion Energy – GlobeNewswire

    Coherent Partners with LLNL’s STARFIRE Team to Drive Breakthroughs in Inertial Fusion Energy

    Gene Associated With Deadly Heart Disease in Golden Retrievers Identified – Technology Networks

    Breakthrough Discovery Uncovers Gene Behind Deadly Heart Disease in Golden Retrievers

    Monkey Island LNG Picks ConocoPhillips’ Liquefaction Technology – Hart Energy

    Monkey Island LNG Selects ConocoPhillips’ Advanced Liquefaction Technology for Next-Gen Energy Solutions

    Credo Technology Group Holding Ltd. (CRDO) Surpasses Q1 Earnings and Revenue Estimates – Yahoo Finance

    Credo Technology Group Surpasses Q1 Earnings and Revenue Expectations

    The Economist is hiring a science and technology correspondent – The Economist

    Exciting Opportunity: Become Our Next Science and Technology Correspondent!

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    The Secret to What Made ‘CarJack’ Work on As the World Turns – yahoo.com

    The Surprising Secret Behind ‘CarJack’s’ Success on As the World Turns

    Victor Garber on his viral “And Just Like That” toilet scene: ‘I was delighted to be doing something ridiculous’ (exclusive) – yahoo.com

    Victor Garber on his viral “And Just Like That” toilet scene: ‘I was delighted to be doing something ridiculous’ (exclusive) – yahoo.com

    Pendulum Announce Homecoming 2026 Australian Tour – yahoo.com

    Pendulum Announces Thrilling Homecoming Tour Across Australia in 2026

    ITV Studios Launches New Entertainment Label – Global Bulletin – IMDb

    ITV Studios Unveils Exciting New Entertainment Label

    TS Entertainment bringing Malibu Jack’s to former Owensboro mall – Lane Report

    TS Entertainment Launches Malibu Jack’s at Former Owensboro Mall Location

    Jenny Han Dropped a Major ‘The Summer I Turned Pretty’ Easter Egg Revealing [SPOILER] – yahoo.com

    Jenny Han Just Unveiled a Huge ‘The Summer I Turned Pretty’ Easter Egg That Changes Everything [SPOILER]

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Health Technology Ecosystem – Centers for Medicare & Medicaid Services | CMS (.gov)

    Discover the Future of Health Technology: Innovations Revolutionizing Patient Care

    Coherent Joins LLNL’s STARFIRE Diode Technology Working Group to Advance Inertial Fusion Energy – GlobeNewswire

    Coherent Partners with LLNL’s STARFIRE Team to Drive Breakthroughs in Inertial Fusion Energy

    Gene Associated With Deadly Heart Disease in Golden Retrievers Identified – Technology Networks

    Breakthrough Discovery Uncovers Gene Behind Deadly Heart Disease in Golden Retrievers

    Monkey Island LNG Picks ConocoPhillips’ Liquefaction Technology – Hart Energy

    Monkey Island LNG Selects ConocoPhillips’ Advanced Liquefaction Technology for Next-Gen Energy Solutions

    Credo Technology Group Holding Ltd. (CRDO) Surpasses Q1 Earnings and Revenue Estimates – Yahoo Finance

    Credo Technology Group Surpasses Q1 Earnings and Revenue Expectations

    The Economist is hiring a science and technology correspondent – The Economist

    Exciting Opportunity: Become Our Next Science and Technology Correspondent!

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Business

Pembrolizumab: Frequently Used Alone Or With Other Cancer Treatments

May 27, 2024
in Business
Pembrolizumab: Frequently Used Alone Or With Other Cancer Treatments
Share on FacebookShare on Twitter

Immune checkpoints are regulators of the immune system. The interaction between PD-L1 (red molecule) … [+] on the surface of a cancer cell (red) and the immune checkpoint PD-1 (blue molecule) on a T-cell (blue) inhibits T-cell killing of tumor cells.

getty

A new era of cancer care emerged in the 2010s with the creation of checkpoint inhibitor therapies. These treatments improved the immune system’s innate ability to kill tumors. Pembrolizumab, sold as Keytruda by Merck & Co., was one of the first inhibitors to hit the market. A trailblazer in its own right, similarly functioning checkpoint inhibitors arose in the wake of pembrolizumab’s approval in 2014. This article details how the therapy works, why it stands apart from other inhibitors and hints at potential future developments.

How Pembrolizumab Works

Pembrolizumab is an anticancer treatment that works by delivering antibodies into the bloodstream intravenously. The antibodies promote antitumor responses by binding to immune checkpoints, proteins found on the surface of immune cells.

Under normal circumstances, checkpoint proteins tamp down the immune system—both to promote immune tolerance, the process by which the body recognizes and avoids attacking its own healthy cells, and to prevent overstimulated immune responses. Tumors also hijack this system to grow freely. Cancer cells quiet immune cells that otherwise would attack by binding to these checkpoint proteins. Checkpoint inhibitors are prized for releasing these T cells which would normally be suppressed by the tumor, allowing them to launch an attack.

Pembrolizumab encourages T cells to fight by releasing their restraints. The therapy targets a specific checkpoint protein found primarily on T cells known as PD-1, or programmed death cell protein 1. By blocking access to the PD-1 checkpoint, other cells can no longer use that protein to stifle T cell activity. The T cell can then activate and retaliate appropriately.

Figure 1: PD-1 checkpoint inhibitor mechanism. Pembrolizumab antibodies target PD-1 (programmed cell … [+] death protein 1) checkpoint proteins found on the surface of white blood T cells. The drug prevents other cells from binding to the checkpoint protein and suppressing T cell activity. The T cell is then free to activate and target tumors. Abbreviations: MHC, major histocompatibility complex; Ag, antigen peptide; TCR, T cell receptor; PD-L1 (programmed death ligand 1)

Access Health International

When is Pembrolizumab Used?

Pembrolizumab can be a potent anti-cancer therapy. It is normally used for advanced cancers that have spread, have relapsed from previous treatments or cannot be removed with surgery alone. Patients receive an infusion every 3 to 6 weeks for up to two years.

How the immunotherapy is administered will vary depending on the disease. For some cancers, doctors can offer pembrolizumab as a first-line treatment. This is the case for qualifying patients with non-small cell lung cancer, throat cancer, gastric cancer or kidney cancer. It can also be given before or after surgery to prevent cancer reoccurrence. Other times, patients must exhaust other treatment alternatives before electing pembrolizumab.

Adding to the complexity, pembrolizumab can be administered alone or alongside other cancer treatments. It is often paired with chemotherapy, radiation and anti-cancer therapies; it is not, however, commonly combined with other checkpoint inhibitors.

The treatment was initially cleared to treat people with advanced melanoma. Today, it elicits antitumor responses in around 18 different types of cancers, including certain blood cancers and various solid tumors. This compatibility can likely be attributed to its broad mechanism of action, as many tumors exploit PD-1 checkpoints to suppress the immune system.

Note, however, that the drug’s efficacy is not uniform. Research suggests that pembrolizumab demonstrates improved efficacy for people with the following cancers:

Melanoma
Non-small Cell Lung Cancer
Head and Neck Squamous Cell Carcinoma
Classic Hodgkin Lymphoma
Solid tumors with certain gene mutations

This inhibitor can clinically benefit other patients as well, albeit to a lesser extent; kidney, bladder, liver, colorectal and breast cancers reside within this list.

The First Approved PD-1 Checkpoint Inhibitor

Of the several checkpoint inhibitors on the market, five of these drugs target PD-1 checkpoint proteins, including pembrolizumab. How does pembrolizumab differ from these other inhibitors?

Pembrolizumab was the first anti-PD-1 therapy to receive federal approval in 2014. Actually, the first-ever approved inhibitor was ipilimumab which, previously described, acts upon a different checkpoint molecule called CTLA-4. All other PD-1 targeting inhibitors arrived after pembrolizumab.

Another divergence is how the immunotherapy is made. Pembrolizumab relies on humanized antibodies. In comparison, its PD-1 competitors use fully human antibodies.

Lastly, pembrolizumab is indicated to treat at least 18 types of cancers. It is used in more combinations against more tumors than ipilimumab or any other federally approved checkpoint inhibitor.

Diagnostic Test

A diagnostic test was developed to help identify which patients would respond best to pembrolizumab. To begin the test, a tissue sample is removed from the tumor. Pathologists then analyze the sample in the lab to see if the tumor cells express a receptor called PD-L1 (programmed death ligand 1) and at what concentration. Tumors that highly express this protein interact more readily with PD-1 checkpoints on T cells and therefore should be more responsive to pembrolizumab’s anti-PD-1 mechanism. The test is available to patients with advanced Head and Neck Squamous Cell Carcinoma (HNSCC), or people with certain breast, cervical, gastric or non⁠–⁠small cell lung cancers.

Possible Adverse Effects

Due to its mechanism of action, all checkpoint inhibitors engage the immune system and can cause unwanted immune-related reactions as a result. In the case of pembrolizumab, PD-1 interactions are crucial to maintaining immune tolerance; releasing this activity can therefore trigger various autoimmune conditions. These diseases include colitis, which resembles inflammatory bowel disease, liver toxicity, adrenal and thyroid disorders, and even type 1 diabetes in a minority of patients. Mild to life-threatening inflammation can arise in the kidneys, lungs and other organs.

Patients commonly experience skin rash, fatigue, nausea, diarrhea, decreased appetite, shortness of breath, headaches, musculoskeletal pain and more.

Combination treatments incur their own additional risks. For example, administering pembrolizumab with axitinib, a targeted cancer drug, can heighten liver toxicity.

Blood tests are required before and after each infusion to closely monitor for any potential adverse effects. Treatment may be stopped altogether if adverse reactions are too severe.

Future Directions

Pembrolizumab has evolved significantly since its release over ten years ago—not in its formula, but in its application and therapeutic potential. Ongoing research continues to refine the therapy’s efficacy and safety profile. Future research endeavors aim to answer crucial questions, such as whether to give pembrolizumab before and after surgery, how to synergize the drug with other cancer treatment modalities, and how adjustments in dosing or scheduling impact patient survival and overall response rates.

Takeaways

Pembrolizumab is a transformative anticancer drug with broad applicability and meaningful impact on patient survival. The treatment demonstrates notable response rates for several advanced cancers, many of which resist other cancer treatments. Looking ahead, research will continue to clarify pembrolizumab’s potential synergies with other treatments and its optimal use in various cancer settings. Future articles will discuss checkpoint inhibitors that employ a similar mechanism of action.

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : Forbes – https://www.forbes.com/sites/williamhaseltine/2024/05/27/anti-cancer-drug-pembrolizumab-frequently-used-alone-or-with-other-treatments

Tags: businessFrequentlyPembrolizumab
Previous Post

Father’s Day Gift Guide 2024: The Best Travel Tees

Next Post

Best Amazon Memorial Day Deals 2024

Pope Leo appeals for peace in Holy Land, Ukraine, areas of world marred by war – Vatican News

Pope Leo appeals for peace in Holy Land, Ukraine, areas of world marred by war – Vatican News

September 7, 2025
The US Economy Is at a Turning Point—and the Stakes Are Higher Than You Might Think – Morningstar

The US Economy Stands at a Crucial Crossroads-Here’s Why It Matters Now More Than Ever

September 7, 2025
The Secret to What Made ‘CarJack’ Work on As the World Turns – yahoo.com

The Surprising Secret Behind ‘CarJack’s’ Success on As the World Turns

September 7, 2025
Fighting a health insurance denial? Here are 7 tips to help – Los Angeles Times

7 Powerful Strategies to Beat Health Insurance Denials and Secure the Coverage You Deserve

September 7, 2025
Florida Surgeon General admits he didn’t study impact before calling to lift vaccine mandate – CNN

Florida Surgeon General admits he didn’t study impact before calling to lift vaccine mandate – CNN

September 7, 2025
WA Department of Ecology decries federal report that downplays climate change – KREM

WA Department of Ecology decries federal report that downplays climate change – KREM

September 7, 2025
This Week in Science: Out-of-Sync Seasons, Anti-Aging Breakthroughs, And More! – yahoo.com

This Week in Science: Out-of-Sync Seasons, Anti-Aging Breakthroughs, And More! – yahoo.com

September 7, 2025
Diagnostic dilemma: Woman’s severe knee pain reveals ‘golden threads’ in her joints – Live Science

Mystery Solved: Woman’s Severe Knee Pain Traced to Shimmering ‘Golden Threads’ in Her Joints

September 7, 2025
PHOTOS: All the celebrities at Aryna Sabalenka’s US Open final victory – Tennis.com

PHOTOS: All the celebrities at Aryna Sabalenka’s US Open final victory – Tennis.com

September 7, 2025
Health Technology Ecosystem – Centers for Medicare & Medicaid Services | CMS (.gov)

Discover the Future of Health Technology: Innovations Revolutionizing Patient Care

September 7, 2025

Categories

Archives

September 2025
MTWTFSS
1234567
891011121314
15161718192021
22232425262728
2930 
« Aug    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (811)
  • Economy (829)
  • Entertainment (21,707)
  • General (16,904)
  • Health (9,871)
  • Lifestyle (842)
  • News (22,149)
  • People (831)
  • Politics (836)
  • Science (16,039)
  • Sports (21,328)
  • Technology (15,809)
  • World (811)

Recent News

Pope Leo appeals for peace in Holy Land, Ukraine, areas of world marred by war – Vatican News

Pope Leo appeals for peace in Holy Land, Ukraine, areas of world marred by war – Vatican News

September 7, 2025
The US Economy Is at a Turning Point—and the Stakes Are Higher Than You Might Think – Morningstar

The US Economy Stands at a Crucial Crossroads-Here’s Why It Matters Now More Than Ever

September 7, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version